Fwd: Compound Tirzepatide & Semaglutide Updates!

Snippet

Body

TJ
Begin forwarded message:

 From: Dave Knapp from On The Pen <onthepen@substack.com>
 Date: March 17, 2026 at 4:03:57 PM EDT
 To: tjphuhs@gmail.com
 Subject: Compound Tirzepatide & Semaglutide Updates!
 Reply-To: Dave Knapp from On The Pen <reply+35w1tf&4iwoe6&&9985d0eabdad8d3ee001e8d18022b7e3ec1f9e03481cf6e0f518cbf32ac3e62e@mg1.substack.com>

  Compound Tirzepatide & Semaglutide Updates! Happy Spring Break to many of you! ͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­͏   ­ Forwarded this email? Subscribe here for more Compound Tirzepatide & Semaglutide Updates! On The Pen GLP-1 News and Ann Metz Mar 17 READ IN APP Happy Spring Break to many of you! While Dave and I are taking a short break from MFW LIVE this week, the news is anything but quiet. Major developments are unfolding, and you can catch up on everything in the latest OTP podcast, where Dave breaks it all down.

 In today’s episode, Dave explores several important topics, including:

 Massive compound shakeup

 Why compound users need this

 Sponsor, Shed obesity care

 Breaking news changed everything

 OTP semaglutide exclusive

 DDC list explained

 Novo’s lab findings

 302% dose shocker

 Catalent’s contamination mess

 Lilly’s B12 tirzepatide bombshell

 Is the molecule changing?

 New oral GLP-1 contender

 MASSIVE: Compound Tirzepatide and Semaglutide Updates!

 Dave Knapp GLP-1 Industry Insider

 Episode



 Do you trust compounded GLP-1s based on real-world experience, or do findings like the ones discussed today change your perspective?

 Leave a comment



 A guest post by Ann Metz Guest writer for https://onthepen.substack.com/ Subscribe to Ann VISIT OUR SPONSORS! You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid.

 Upgrade to paid Share Like Comment Restack © 2026 David Knapp
On The Pen, PO Box 541, Cedar Falls, IA 50613
 Unsubscribe